| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/06/2004 | US6673580 Genetically engineering thrombopoietin for use in the treatment of thrombocytopenia; obtain polypeptide, adjust epitopes, recover polypeptide, administer to patients |
| 01/06/2004 | US6673575 Use of cultured, recombinant eukaryotic cells in the production of glycoproteins for pharmaceutical use especially given the control in degree of glycosylation afforded by the procedure |
| 01/06/2004 | US6673573 Expression of immunoglobulin-cytokine fusion proteins in malignant B cells |
| 01/06/2004 | US6673571 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 01/06/2004 | US6673569 Dsb protein family, includes dsba (formation of) and dsbc (isomerizing of) disulfide bonds, and dsbb or dsbd to control the reactivity of dsba/dsbc; use to study coexpression effects of these proteins in secretion of a foreign protein |
| 01/06/2004 | US6673351 Immunotherapeutic agent comprising purified protein extract derived from killed cells of amastigotes and leishmania |
| 01/06/2004 | US6673349 Crosslinking; forming vaccines |
| 01/06/2004 | US6673348 Heat shock protein-based vaccines and immunotherapies |
| 01/06/2004 | US6673344 Antibodies to human CKβ-10/MCP-4 |
| 01/06/2004 | US6673342 Administering dimeric or polymeric iga antibodies that are for useful in preventing or inhibiting infection by pathogens |
| 01/06/2004 | CA2142712C Bordetella bronchiseptica vaccine |
| 01/06/2004 | CA2135083C Antibodies to p-selectin and their uses |
| 01/06/2004 | CA2134094C Production of recombinant human lactoferrin |
| 01/06/2004 | CA2128208C Novel seven transmembrane receptors |
| 01/05/2004 | CA2432942A1 Carbohydrate deficient transferrin (cdt)-specific antibodies, their preparation and use |
| 01/02/2004 | EP1375666A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof |
| 01/02/2004 | EP1375664A1 Method for the sectetion and production of protein |
| 01/02/2004 | EP1375663A1 Novel protein, dna thereof and use of the same |
| 01/02/2004 | EP1375639A1 Selection media for beauveriolide i or beauveriolide iii and process for selectively producing these substances |
| 01/02/2004 | EP1375520A1 Apoptosis induced by monoclonal antibody anti-Her2 |
| 01/02/2004 | EP1375518A1 Anti-osteopontin antibody and use thereof |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1375515A2 Polypeptide, cDNA encoding the same, and use thereof |
| 01/02/2004 | EP1375514A2 5'ESTs for secreted proteins expressed in various tissues |
| 01/02/2004 | EP1373571A2 Functional surface display of polypeptides |
| 01/02/2004 | EP1373570A1 Improved in vitro synthesis system |
| 01/02/2004 | EP1373547A1 Control of glycoforms in igg |
| 01/02/2004 | EP1373535A2 Improved gene expression |
| 01/02/2004 | EP1373524A2 Cytomegalovirus intron a fragments |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373510A2 Mutant allergens |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373503A2 Neurotrophic factors |
| 01/02/2004 | EP1373493A1 Coagulation factor vii derivatives |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373477A2 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 01/02/2004 | EP1373322A1 Novel compound for treatment of allergy and asthma |
| 01/02/2004 | EP1373321A2 Modified antibodies and methods of use |
| 01/02/2004 | EP1373320A2 Method for preparing and selecting antibodies |
| 01/02/2004 | EP1373319A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 01/02/2004 | EP1373318A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 01/02/2004 | EP1373312A1 Shellfish protein |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373295A2 Regulatable growth of filamentous fungi |
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1372741A2 Morpholino imaging and therapy |
| 01/02/2004 | EP1372736A2 Anti-neovasculature preparations for cancer |
| 01/02/2004 | EP1372718A2 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 01/02/2004 | EP1372711A2 Compositions and methods comprising west nile virus polypeptides |
| 01/02/2004 | EP1372696A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/02/2004 | EP1372690A2 93870, a human g-protein coupled receptor and uses therefor |
| 01/02/2004 | EP0506780B2 Stable integration of dna in bacterial genomes |
| 01/01/2004 | US20040003425 Nav2 channel gene-deficient non-human animals |
| 01/01/2004 | US20040003422 An expression cassette containing the proopiomelanocortin (POMC) enhancer, and a nucleic acid sequence encoding POMC contains at least one exon, wherein a polylinker having an unique site for restriction enzyme is inserted into the exon; gene regulates weight and fat mass |
| 01/01/2004 | US20040003419 Novel taste receptors in Drosophila |
| 01/01/2004 | US20040002458 Pharmaceutical compositions and methods using natriuretic peptides |
| 01/01/2004 | US20040002449 METH1 and METH2 polynucleotides and polypeptides |
| 01/01/2004 | US20040002439 Human voltage gated sodium channel beta1A subunit and methods of use |
| 01/01/2004 | US20040002144 Extrapolating the structure-binding site by replacing, inserting or deleting amino acids; x-ray crystal structure analysis; streptoverticillium mobaraense |
| 01/01/2004 | US20040002141 Methods and compositions for propagating vectors containing toxic cDNAs and ion channel assay systems |
| 01/01/2004 | US20040002139 Methods for making recombinant proteins using apoptosis inhibitors |
| 01/01/2004 | US20040002136 Mutant Chrysosporium strain comprising a nucleic acid sequence encoding a polypeptide; expressing and secreting heterologous proteins |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002114 Nucleic acids encoding a G-protein coupled receptor involved in islet cell signaling |
| 01/01/2004 | US20040002109 Process for identifying modulators of G-protein-coupled receptors |
| 01/01/2004 | US20040002103 Synthetic ligation reassembly in directed evolution |
| 01/01/2004 | US20040002088 Identification and isolation of novel DNA and to the recombinant production of polypeptides having sequence similarity to Glial Cell line-derived Neurotrophic Factor Receptor (GDNFR) |
| 01/01/2004 | US20040002061 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells |
| 01/01/2004 | US20040002057 Cloning vectors and methods for producing a library of DNA molecules capable of expressing a fusion polypeptide on the surface of a filamentous phage particle |
| 01/01/2004 | US20040001854 Isolated, genetic engineered polypeptide |
| 01/01/2004 | US20040001840 Cancer-linked gene as target for chemotherapy |
| 01/01/2004 | US20040001832 Childhood obesity; antidiabetic agents; culture product; hybrid nucleic acid |
| 01/01/2004 | US20040001828 Treatment methods using anti-CD22 antibodies |
| 01/01/2004 | US20040001790 Methods for diagnosis and treatment of tumours |
| 12/31/2003 | WO2004001381A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 12/31/2003 | WO2004001048A1 Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 12/31/2003 | WO2004001042A2 Microarrays displaying encoded molecules |
| 12/31/2003 | WO2004001041A1 Expression vector, host, fused protein, process for producing fused protein and process for producing protein |
| 12/31/2003 | WO2004001007A2 Buffered formulations for concentrating antibodies and methods of use thereof |
| 12/31/2003 | WO2004001004A2 Membrane associated tumor endothelium markers |
| 12/31/2003 | WO2004000997A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/31/2003 | WO2004000881A1 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 12/31/2003 | WO2004000879A1 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives |
| 12/31/2003 | WO2004000415A2 Tissue reconstruction and regeneration |
| 12/31/2003 | WO2004000349A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 12/31/2003 | WO2004000207A2 Toxin-phage bacteriocide antibiotic and uses thereof |
| 12/31/2003 | WO2003072036A3 Treatment methods using anti-cd22 antibodies |
| 12/31/2003 | WO2003064471A3 Gene for peripheral arterial occlusive disease |
| 12/31/2003 | WO2003055916A3 Adiponectin fragments and conjugates |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2003048208A3 Expression control using variable intergenic sequences |
| 12/31/2003 | WO2003040335A3 Engineering of leader peptides for the secretion of recombinant proteins in bacteria |
| 12/31/2003 | WO2003039344A3 Methods and compositions for correction of cardiac conduction disturbances |
| 12/31/2003 | WO2003027305A3 Optimization of temperature shifting in high cell-density fermentations |
| 12/31/2003 | WO2003022996A3 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 12/31/2003 | WO2003022879B1 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them |
| 12/31/2003 | WO2003020759A9 A caspase- 8 binding protein, its preparation and use |
| 12/31/2003 | WO2003001985A3 Method for detection of melanoma |
| 12/31/2003 | WO2002101006A3 Production of proteins in plants |